Click for best price
Epilepsy Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 4907.2 million
|
Forecast Market size by 2029 |
US$ 5939.7 million
|
| Growth Rate |
CAGR of 2.8% |
Number of Pages |
107 Pages |
Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.
This report aims to provide a comprehensive presentation of the global market for Epilepsy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epilepsy Drugs. This report contains market size and forecasts of Epilepsy Drugs in global, including the following market information:
The global Epilepsy Drugs market was valued at US$ 4907.2 million in 2022 and is projected to reach US$ 5939.7 million by 2029, at a CAGR of 2.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In terms of geography, the Americas led the global epilepsy drugs market and is likely to hold close to 50% of the revenue market shares. The growth of this market in the region is due to the high prevalence of the disorder and the availability of treatment options in the region, especially in the developed markets such as the US and Canada.
We surveyed the Epilepsy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Epilepsy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Epilepsy Drugs Market Segment Percentages, by Type, 2022 (%)
- First Generation
- Second Generation
Global Epilepsy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Epilepsy Drugs Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Epilepsy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Epilepsy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Epilepsy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Epilepsy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Abbott Laboratories
- GlaxoSmithKline Plc
- UCB
- Cephalon
- Johnson & Johnson
- Pfizer
- Novartis AG
- Abbvie
- Janssen Pharmaceuticals
- Sunovion Pharmaceuticals
- Bausch Health
- Sanofi S.A
- Takeda
- Eisai
- F. Hoffmann-La Roche
Outline of Major Chapters:
- Chapter 1: Introduces the definition of Epilepsy Drugs, market overview.
- Chapter 2: Global Epilepsy Drugs market size in revenue.
- Chapter 3: Detailed analysis of Epilepsy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
- Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
- Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
- Chapter 6: Sales of Epilepsy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
- Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
- Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Epilepsy Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 4907.2 million
|
| Forecast Market size by 2029 |
US$ 5939.7 million
|
| Growth Rate |
CAGR of 2.8% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
107 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Epilepsy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Epilepsy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Epilepsy Drugs Overall Market Size
2.1 Global Epilepsy Drugs Market Size: 2022 VS 2029
2.2 Global Epilepsy Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Epilepsy Drugs Players in Global Market
3.2 Top Global Epilepsy Drugs Companies Ranked by Revenue
3.3 Global Epilepsy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Epilepsy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Epilepsy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Epilepsy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Epilepsy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Epilepsy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Epilepsy Drugs Market Size Markets, 2022 & 2029
4.1.2 First Generation
4.1.3 Second Generation
4.2 By Type - Global Epilepsy Drugs Revenue & Forecasts
4.2.1 By Type - Global Epilepsy Drugs Revenue, 2018-2023
4.2.2 By Type - Global Epilepsy Drugs Revenue, 2024-2029
4.2.3 By Type - Global Epilepsy Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Epilepsy Drugs Market Size, 2022 & 2029
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global Epilepsy Drugs Revenue & Forecasts
5.2.1 By Application - Global Epilepsy Drugs Revenue, 2018-2023
5.2.2 By Application - Global Epilepsy Drugs Revenue, 2024-2029
5.2.3 By Application - Global Epilepsy Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Epilepsy Drugs Market Size, 2022 & 2029
6.2 By Region - Global Epilepsy Drugs Revenue & Forecasts
6.2.1 By Region - Global Epilepsy Drugs Revenue, 2018-2023
6.2.2 By Region - Global Epilepsy Drugs Revenue, 2024-2029
6.2.3 By Region - Global Epilepsy Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Epilepsy Drugs Revenue, 2018-2029
6.3.2 US Epilepsy Drugs Market Size, 2018-2029
6.3.3 Canada Epilepsy Drugs Market Size, 2018-2029
6.3.4 Mexico Epilepsy Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Epilepsy Drugs Revenue, 2018-2029
6.4.2 Germany Epilepsy Drugs Market Size, 2018-2029
6.4.3 France Epilepsy Drugs Market Size, 2018-2029
6.4.4 U.K. Epilepsy Drugs Market Size, 2018-2029
6.4.5 Italy Epilepsy Drugs Market Size, 2018-2029
6.4.6 Russia Epilepsy Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Epilepsy Drugs Market Size, 2018-2029
6.4.8 Benelux Epilepsy Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Epilepsy Drugs Revenue, 2018-2029
6.5.2 China Epilepsy Drugs Market Size, 2018-2029
6.5.3 Japan Epilepsy Drugs Market Size, 2018-2029
6.5.4 South Korea Epilepsy Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Epilepsy Drugs Market Size, 2018-2029
6.5.6 India Epilepsy Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Epilepsy Drugs Revenue, 2018-2029
6.6.2 Brazil Epilepsy Drugs Market Size, 2018-2029
6.6.3 Argentina Epilepsy Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Epilepsy Drugs Revenue, 2018-2029
6.7.2 Turkey Epilepsy Drugs Market Size, 2018-2029
6.7.3 Israel Epilepsy Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Epilepsy Drugs Market Size, 2018-2029
6.7.5 UAE Epilepsy Drugs Market Size, 2018-2029
7 Epilepsy Drugs Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Epilepsy Drugs Major Product Offerings
7.1.4 Abbott Laboratories Epilepsy Drugs Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 GlaxoSmithKline Plc
7.2.1 GlaxoSmithKline Plc Company Summary
7.2.2 GlaxoSmithKline Plc Business Overview
7.2.3 GlaxoSmithKline Plc Epilepsy Drugs Major Product Offerings
7.2.4 GlaxoSmithKline Plc Epilepsy Drugs Revenue in Global Market (2018-2023)
7.2.5 GlaxoSmithKline Plc Key News & Latest Developments
7.3 UCB
7.3.1 UCB Company Summary
7.3.2 UCB Business Overview
7.3.3 UCB Epilepsy Drugs Major Product Offerings
7.3.4 UCB Epilepsy Drugs Revenue in Global Market (2018-2023)
7.3.5 UCB Key News & Latest Developments
7.4 Cephalon
7.4.1 Cephalon Company Summary
7.4.2 Cephalon Business Overview
7.4.3 Cephalon Epilepsy Drugs Major Product Offerings
7.4.4 Cephalon Epilepsy Drugs Revenue in Global Market (2018-2023)
7.4.5 Cephalon Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Epilepsy Drugs Major Product Offerings
7.5.4 Johnson & Johnson Epilepsy Drugs Revenue in Global Market (2018-2023)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Epilepsy Drugs Major Product Offerings
7.6.4 Pfizer Epilepsy Drugs Revenue in Global Market (2018-2023)
7.6.5 Pfizer Key News & Latest Developments
7.7 Novartis AG
7.7.1 Novartis AG Company Summary
7.7.2 Novartis AG Business Overview
7.7.3 Novartis AG Epilepsy Drugs Major Product Offerings
7.7.4 Novartis AG Epilepsy Drugs Revenue in Global Market (2018-2023)
7.7.5 Novartis AG Key News & Latest Developments
7.8 Abbvie
7.8.1 Abbvie Company Summary
7.8.2 Abbvie Business Overview
7.8.3 Abbvie Epilepsy Drugs Major Product Offerings
7.8.4 Abbvie Epilepsy Drugs Revenue in Global Market (2018-2023)
7.8.5 Abbvie Key News & Latest Developments
7.9 Janssen Pharmaceuticals
7.9.1 Janssen Pharmaceuticals Company Summary
7.9.2 Janssen Pharmaceuticals Business Overview
7.9.3 Janssen Pharmaceuticals Epilepsy Drugs Major Product Offerings
7.9.4 Janssen Pharmaceuticals Epilepsy Drugs Revenue in Global Market (2018-2023)
7.9.5 Janssen Pharmaceuticals Key News & Latest Developments
7.10 Sunovion Pharmaceuticals
7.10.1 Sunovion Pharmaceuticals Company Summary
7.10.2 Sunovion Pharmaceuticals Business Overview
7.10.3 Sunovion Pharmaceuticals Epilepsy Drugs Major Product Offerings
7.10.4 Sunovion Pharmaceuticals Epilepsy Drugs Revenue in Global Market (2018-2023)
7.10.5 Sunovion Pharmaceuticals Key News & Latest Developments
7.11 Bausch Health
7.11.1 Bausch Health Company Summary
7.11.2 Bausch Health Business Overview
7.11.3 Bausch Health Epilepsy Drugs Major Product Offerings
7.11.4 Bausch Health Epilepsy Drugs Revenue in Global Market (2018-2023)
7.11.5 Bausch Health Key News & Latest Developments
7.12 Sanofi S.A
7.12.1 Sanofi S.A Company Summary
7.12.2 Sanofi S.A Business Overview
7.12.3 Sanofi S.A Epilepsy Drugs Major Product Offerings
7.12.4 Sanofi S.A Epilepsy Drugs Revenue in Global Market (2018-2023)
7.12.5 Sanofi S.A Key News & Latest Developments
7.13 Takeda
7.13.1 Takeda Company Summary
7.13.2 Takeda Business Overview
7.13.3 Takeda Epilepsy Drugs Major Product Offerings
7.13.4 Takeda Epilepsy Drugs Revenue in Global Market (2018-2023)
7.13.5 Takeda Key News & Latest Developments
7.14 Eisai
7.14.1 Eisai Company Summary
7.14.2 Eisai Business Overview
7.14.3 Eisai Epilepsy Drugs Major Product Offerings
7.14.4 Eisai Epilepsy Drugs Revenue in Global Market (2018-2023)
7.14.5 Eisai Key News & Latest Developments
7.15 F. Hoffmann-La Roche
7.15.1 F. Hoffmann-La Roche Company Summary
7.15.2 F. Hoffmann-La Roche Business Overview
7.15.3 F. Hoffmann-La Roche Epilepsy Drugs Major Product Offerings
7.15.4 F. Hoffmann-La Roche Epilepsy Drugs Revenue in Global Market (2018-2023)
7.15.5 F. Hoffmann-La Roche Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Epilepsy Drugs Market Opportunities & Trends in Global Market
Table 2. Epilepsy Drugs Market Drivers in Global Market
Table 3. Epilepsy Drugs Market Restraints in Global Market
Table 4. Key Players of Epilepsy Drugs in Global Market
Table 5. Top Epilepsy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Epilepsy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Epilepsy Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Epilepsy Drugs Product Type
Table 9. List of Global Tier 1 Epilepsy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Epilepsy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Epilepsy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Epilepsy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Epilepsy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Epilepsy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Epilepsy Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Epilepsy Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Epilepsy Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Epilepsy Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Epilepsy Drugs Product Offerings
Table 32. Abbott Laboratories Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. GlaxoSmithKline Plc Company Summary
Table 35. GlaxoSmithKline Plc Epilepsy Drugs Product Offerings
Table 36. GlaxoSmithKline Plc Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. GlaxoSmithKline Plc Key News & Latest Developments
Table 38. UCB Company Summary
Table 39. UCB Epilepsy Drugs Product Offerings
Table 40. UCB Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. UCB Key News & Latest Developments
Table 42. Cephalon Company Summary
Table 43. Cephalon Epilepsy Drugs Product Offerings
Table 44. Cephalon Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Cephalon Key News & Latest Developments
Table 46. Johnson & Johnson Company Summary
Table 47. Johnson & Johnson Epilepsy Drugs Product Offerings
Table 48. Johnson & Johnson Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Johnson & Johnson Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Epilepsy Drugs Product Offerings
Table 52. Pfizer Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Novartis AG Company Summary
Table 55. Novartis AG Epilepsy Drugs Product Offerings
Table 56. Novartis AG Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Novartis AG Key News & Latest Developments
Table 58. Abbvie Company Summary
Table 59. Abbvie Epilepsy Drugs Product Offerings
Table 60. Abbvie Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Abbvie Key News & Latest Developments
Table 62. Janssen Pharmaceuticals Company Summary
Table 63. Janssen Pharmaceuticals Epilepsy Drugs Product Offerings
Table 64. Janssen Pharmaceuticals Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Janssen Pharmaceuticals Key News & Latest Developments
Table 66. Sunovion Pharmaceuticals Company Summary
Table 67. Sunovion Pharmaceuticals Epilepsy Drugs Product Offerings
Table 68. Sunovion Pharmaceuticals Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Sunovion Pharmaceuticals Key News & Latest Developments
Table 70. Bausch Health Company Summary
Table 71. Bausch Health Epilepsy Drugs Product Offerings
Table 72. Bausch Health Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Bausch Health Key News & Latest Developments
Table 74. Sanofi S.A Company Summary
Table 75. Sanofi S.A Epilepsy Drugs Product Offerings
Table 76. Sanofi S.A Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Sanofi S.A Key News & Latest Developments
Table 78. Takeda Company Summary
Table 79. Takeda Epilepsy Drugs Product Offerings
Table 80. Takeda Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Takeda Key News & Latest Developments
Table 82. Eisai Company Summary
Table 83. Eisai Epilepsy Drugs Product Offerings
Table 84. Eisai Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Eisai Key News & Latest Developments
Table 86. F. Hoffmann-La Roche Company Summary
Table 87. F. Hoffmann-La Roche Epilepsy Drugs Product Offerings
Table 88. F. Hoffmann-La Roche Epilepsy Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. F. Hoffmann-La Roche Key News & Latest Developments
List of Figures
Figure 1. Epilepsy Drugs Segment by Type in 2022
Figure 2. Epilepsy Drugs Segment by Application in 2022
Figure 3. Global Epilepsy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Epilepsy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Epilepsy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Epilepsy Drugs Revenue in 2022
Figure 8. By Type - Global Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Epilepsy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 16. US Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 28. China Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Epilepsy Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Epilepsy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Abbott Laboratories Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GlaxoSmithKline Plc Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. UCB Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cephalon Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Johnson & Johnson Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Pfizer Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Novartis AG Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Abbvie Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Janssen Pharmaceuticals Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Sunovion Pharmaceuticals Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Bausch Health Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sanofi S.A Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Takeda Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Eisai Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. F. Hoffmann-La Roche Epilepsy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
